Oxford Biomedica plc (LON:OXB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
502.00
+12.00 (2.45%)
Sep 25, 2026, 3:06 PM GMT

Oxford Biomedica Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-40.73-30.13-43.19-157.49-39.1619.01
Depreciation & Amortization
14.5717.5820.0921.5120.2912.46
Other Amortization
3.382.272.347.26.66-
Loss (Gain) From Sale of Assets
0.110.020.29-0.82-21.33-
Asset Writedown & Restructuring Costs
7.64-0.1899.29--
Loss (Gain) From Sale of Investments
----0.050.17
Stock-Based Compensation
5.024.681.693.526.473.98
Other Operating Activities
8.992.862.32-19.179.52.75
Change in Accounts Receivable
-14.79-21.66-33.3428.79-17.886.89
Change in Inventory
-9.01-1.852.19-0.250.67-2.61
Change in Accounts Payable
3.028.722.89-18.1316.96-0.66
Change in Unearned Revenue
1.2718.18-6.057.035.16-16.53
Change in Other Net Operating Assets
-0.02-0.16-0.080--
Operating Cash Flow
-20.560.51-50.67-28.52-12.6225.46
Operating Cash Flow Growth
-----716.91%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10.15-4.76-7.5-9.83-16.3-9.46
Sale of Property, Plant & Equipment
-0.19--8.3960-
Cash Acquisitions
-3.34-3.349--99.21-
Sale (Purchase) of Intangibles
-0.24-----
Other Investing Activities
3.132.384.124.25-0.96-
Investing Cash Flow
-10.79-5.725.632.81-56.46-9.46

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-41.95--64.87-
Long-Term Debt Repaid
--42.84-5.19-3.12-32.54-4.52
Lease Payments
-6.92-4.06-4.72-3.12-1.12-4.52
Net Debt Issued (Repaid)
7.64-0.88-5.19-3.1232.32-4.52
Issuance of Common Stock
58.4558.0617.530.6580.1551.6
Other Financing Activities
-13.63-14.91-9.43-10.24-13.85-0.87
Financing Cash Flow
52.4642.262.91-12.798.6246.21

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.3-0.81-0.940.852.8-
Net Cash Flow
21.4136.23-43.07-37.5732.3462.2

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-30.71-4.25-58.16-38.35-28.9115.99
Free Cash Flow Growth
------
Free Cash Flow Margin
-17.51%-2.52%-45.16%-42.83%-20.65%11.20%
Free Cash Flow Per Share
-0.26-0.04-0.56-0.40-0.300.19
Levered Free Cash Flow
-25.92-0.01-36.34-17.07-12.8210.88
Unlevered Free Cash Flow
-16.568.65-30.19-10.4-7.9811.42
Free Cash Flow After Leases
-37.62-8.32-62.89-41.47-30.0311.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.6312.929.4310.247.680.87
Cash Income Tax Paid
--5.13--7.51-0.56-0.99
Change in Working Capital
-19.533.23-34.3817.464.91-12.91